RPG LIFE SCIENCES share price has plunged 6% and is presently trading at Rs 2,332.0.
Meanwhile, the BSE HEALTHCARE index is at 43,544.3 (down 1.2%).
Among the top losers in the BSE HEALTHCARE index today are MAX HEALTHCARE INSTITUTE (down 4.1%) and APOLLO HOSPITALS (down 3.5%).
Biocon (up 8.3%) and GLAND PHARMA (up 2.0%) are among the top gainers today.
Over the last one year, RPG LIFE SCIENCES has moved up from Rs 1,449.5 to Rs 2,332.0, registering a gain of Rs 882.5 (up 60.9%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,385.6 to 43,544.3, registering a gain of 53.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 209.9%), SUVEN PHARMACEUTICALS (up 118.4%) and Glenmark Pharma (up 116.4%).
For Investors: Our Big Prediction
The BSE Sensex is at 79,346.6 (down 0.2%).
The top losers among the BSE Sensex today are Asian Paints (down 8.7%) and M&M (down 2.7%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.
In the meantime, NSE Nifty is at 24,092.4 (down 0.2%). Asian Paints and APOLLO HOSPITALS are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,942.4 to 79,346.6, registering a gain of 14,404.2 points (up 22.2%).
RPG LIFE SCIENCES net profit fell 83.8% YoY to Rs 42 million for the quarter ended September 2024, compared to a profit of Rs 259 million a year ago. Net sales rose 12.1% to Rs 1,722 million during the period as against Rs 1,536 million in July-September 2023.
For the year ended March 2024, RPG LIFE SCIENCES reported 29.6% increase in net profit to Rs 877 million compared to net profit of Rs 676 million during FY23. Revenue of the company grew 13.5% to Rs 5,821 million during FY24.
The current Price to earnings ratio of RPG LIFE SCIENCES, based on rolling 12 month earnings, stands at 54.6.
Equitymaster requests your view! Post a comment on "RPG LIFE SCIENCES Plunges 6%; BSE HEALTHCARE Index Down 1.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!